Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	67.28	55.14	97.47	79.51	164.89	87.43
Short-Term Investments	253.04	202.96	326.68	446.73	285.61	211.94
Cash & Short-Term Investments	320.32	258.11	424.15	526.24	450.5	299.37
Cash Growth	4.78%	-39.15%	-19.40%	16.81%	50.48%	958.99%
Accounts Receivable	71.48	69.02	51.13	52.75	139.15	185.24
Other Receivables	8.96	8.01	6.31	22.36	4.15	18.83
Receivables	80.44	77.03	57.45	75.11	143.3	204.06
Prepaid Expenses	5.74	6.63	7.74	6.81	4.24	3.68
Other Current Assets	10.28	11.81	18.5	19.71	13.92	16.51
Total Current Assets	416.78	353.57	507.85	627.87	611.96	523.62
Property, Plant & Equipment	112.78	111.72	95.62	98.92	71.16	41.03
Long-Term Investments	519.04	595.28	444.01	339.03	507.01	132.5
Goodwill	22.06	22.06	22.06	143.03	50.9	-
Other Intangible Assets	133.01	134.98	143.05	150.64	35.91	-
Long-Term Deferred Tax Assets	-	-	-	3.5	0.76	1.63
Other Long-Term Assets	2.08	2.37	22.75	23.05	1.02	1.69
Total Assets	1,206	1,220	1,235	1,386	1,279	700.46
Accounts Payable	18.24	18.36	15.36	23.09	20.49	26.39
Accrued Expenses	15.01	22.44	26.24	17.91	15.52	8.54
Short-Term Debt	-	-	-	15	21.28	15.02
Current Portion of Long-Term Debt	0.48	0.41	1.18	5.64	-	-
Current Portion of Leases	1.68	1.84	4.5	7.08	2.17	-
Current Income Taxes Payable	-	-	-	-	0.79	53.32
Current Unearned Revenue	2.82	2.23	2.87	3.2	14.57	26.58
Other Current Liabilities	27.7	27.61	22.86	16.2	30.49	0.27
Total Current Liabilities	65.92	72.9	73.02	88.11	105.31	130.12
Long-Term Debt	1.96	2.49	2.96	-	-	-
Long-Term Leases	4.16	4.48	7.91	10.61	6.74	0.57
Long-Term Deferred Tax Liabilities	6.24	6.37	7.96	-	-	-
Other Long-Term Liabilities	4.7	4.56	10.19	17.46	0.79	0.39
Total Liabilities	82.97	90.81	102.04	116.18	112.84	131.07
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	543.9	543.13	501.72	486.59	501.91	418.07
Retained Earnings	578.94	590.47	633.18	801	657.6	150.88
Comprehensive Income & Other	4.34	-0.37	1.21	-20.9	-0.76	0.44
Total Common Equity	1,127	1,133	1,136	1,267	1,159	569.39
Minority Interest	-4.41	-4.07	-2.82	3.19	7.13	-
Shareholders' Equity	1,123	1,129	1,133	1,270	1,166	569.39
Total Liabilities & Equity	1,206	1,220	1,235	1,386	1,279	700.46
Total Debt	8.28	9.23	16.56	38.33	30.2	15.59
Net Cash (Debt)	806.15	819.23	831.17	814.56	905.35	416.28
Net Cash Growth	-3.18%	-1.44%	2.04%	-10.03%	117.48%	516.35%
Net Cash Per Share	26.43	27.10	27.91	26.31	29.23	17.30
Filing Date Shares Outstanding	30.44	30.83	29.78	29.52	30.25	28.87
Total Common Shares Outstanding	30.62	30.84	29.65	29.44	30.16	28.18
Working Capital	350.87	280.67	434.83	539.77	506.65	393.5
Book Value Per Share	36.81	36.74	38.31	43.03	38.42	20.21
Tangible Book Value	972.11	976.2	970.99	973.02	1,072	569.39
Tangible Book Value Per Share	31.75	31.65	32.75	33.05	35.54	20.21
Land	17.35	17.35	8.8	7.5	7.5	7.5
Buildings	49.63	49.61	17.53	12.6	10.67	7.44
Machinery	78.89	76.07	73.65	71.97	51.22	31.6
Leasehold Improvements	4.31	3.32	11.22	11.8	4	1.58

Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q